The Impact of Transcutaneous Spinal Cord Stimulation (TSCS) and Gait Training on Walking Function in Patients With Spinal Cord Injury
TSCS
1 other identifier
interventional
11
1 country
1
Brief Summary
Aim 1: Determine the neurophysiologic impact of Transcutaneous Spinal Cord Stimulation (TSCS) within a single session. The investigators hypothesize that subjects will demonstrate increased volitional muscle activity and strength with TSCS. This will be assessed by surface EMG and hand-held dynamometry of the dominant-side quadriceps muscle during maximum volitional contraction (MVC) and measurement of gait speed. Subjects will be tested in both TSCS and sham conditions. Aim 2: Determine the impact of TSCS and gait training on walking function. The investigators hypothesize that concurrent TSCS and gait training will augment walking function in subjects with iSCI, as compared to gait training alone. Subjects will participate in an eight-week program of gait training with TSCS and be assessed with clinically relevant outcome measures, to include the Timed Up and Go, 10-Meter Walk Test, Walking Index for Spinal Cord Injury II, and 6-Minute Walk Test.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jan 2017
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 5, 2017
CompletedFirst Submitted
Initial submission to the registry
December 12, 2017
CompletedFirst Posted
Study publicly available on registry
December 27, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 14, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
October 28, 2020
CompletedFebruary 17, 2021
February 1, 2021
1.7 years
December 12, 2017
February 16, 2021
Conditions
Outcome Measures
Primary Outcomes (1)
Change in walking speed
10-Meter Walk Test
at the start, week 4, and week 8
Secondary Outcomes (3)
Change in walking capacity
at the start, week 4, and week 8
Change in level of assistance and assistive device for walking
at the start, week 4, and week 8
Change in walking endurance
at the start, week 4, and week 8
Study Arms (1)
TSCS and gait training
EXPERIMENTALInterventions
TSCS will be applied using a midline electrode placed on the skin between spinous process T11 -T12 and two electrodes placed symmetrically on the skin over the lower abdomen as anodes. A symmetrical biphasic rectangular waveform, at 50 Hz and 1 millisecond, is used to provide 30 continuous minutes of stimulation. Subjects will participate in 24 two-hour sessions of physical therapy over eight weeks. In each session, subjects will receive TSCS continuously for 30 minutes, using the parameters outlined above. During stimulation, subjects will participate in strengthening, segmental task practice, and gait-based interventions. Participation in gait training will continue following the stimulation period for the duration of the session.
Eligibility Criteria
You may qualify if:
- years old
- \>1 year post SCI
- Non-progressive SCI
- Neurological level above T10
- Tolerates upright position for \>30 minutes
- Medically stable (no hospitalizations in last 3 months)
- Able to comply with procedures and follow up
- Are legally able to make their own health care decisions
You may not qualify if:
- Progressive SCI/D (MS, ALS, ADEM, etc.)
- Open wounds at stimulation site
- Pregnant women
- ROM limitations impacting gait training
- Cardiac pacemaker/defibrillator
- Active cancer diagnosis
- Currently receiving TSCS
- Evidence of uncontrolled autonomic dysreflexia
- Non-English speaking subjects will not be targeted
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Rebecca Martin, OTR/L, OTD, CPAM
Baltimore, Maryland, 21205, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Masking Details
- All assessors will be blind to intervention
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Manager Clinical Education and Training, International Center for Spinal Cord Injury Assistant Professor, Johns Hopkins School of Medicine, Dept. of Physical Medicine and Rehabilitation
Study Record Dates
First Submitted
December 12, 2017
First Posted
December 27, 2017
Study Start
January 5, 2017
Primary Completion
September 14, 2018
Study Completion
October 28, 2020
Last Updated
February 17, 2021
Record last verified: 2021-02
Data Sharing
- IPD Sharing
- Will not share